Günter Graubach – Founder and Chairman
Founder, Chairman and owner Curatis AG. Previously Vice President Business Development and Project Management at MyoContract and instrumental in initial build-up and development of the company and its lead project idebenone (IPO on Swiss stock exchange in 2006 as Santhera Pharmaceuticals). Held various commercial management positions at Hoffmann-La Roche in Switzerland, USA, and Latin America. Graduated with a Master`s Degree in Business from the University of Lyon, France and a post graduate degree in Economics from the University of Constance, Germany.
Dr. Roland Schomer – Founder and Chief Executive Officer
Previously at Novartis in Basel, Switzerland in charge of global brands with sales of CHF 600+ million. General Manager Germany at Actelion. Held various positions of increasing responsibility within the marketing and sales function at Pfizer and Parke Davis in Germany and Middle East, successfully managing brands across multiple therapeutic areas. Received his MD degree from the Johannes-Gutenberg University, School of Medicine, Mainz, Germany and graduated with an MBA from Kellogg School of Management and WHU.
Dr. Roland Rutschmann – Founder
Board Member Curatis AG. Previously Vice President/General Manager at Orphan Europe in Paris (France), Regional Vice President/General Manager and Vice President Strategic Marketing Europe at Actelion. Worked for Hoffmann-La Roche and Warner-Lambert in Switzerland, The Netherlands and Germany in various managerial marketing and sales positions. Holds a PhD in Cell Biology/Immunology from the University of Basel. Attained commercial education at INSEAD.
Prof. Arnim Pause, M.Sc., Ph.D. – Founder, Director and Scientific Advisor
Professor of Biochemistry at Goodman Cancer Research Center and Department of Biochemistry, McGill University, Montreal, Canada; scientific advisor and consultant for pharmaceutical and biotechnology companies; published more than 80 papers/book chapters and many patents; previously held R&D management positions at Boehringer Ingelheim and Max-Plank Institute for Biochemistry; graduated with a B.Sc. and M.Sc. Degree in Molecular Biology from the University of Constance, Germany, Ph.D. Degree in Biochemistry from McGill University and a postdoctoral fellowship at the NIH, USA; extensive research experience in molecular medicine.
Neil Oughton – Director and Company Secretary
Founder and Director of V Pharma, UK. Held various commercial management positions at Vidant Pharma, Fulcrum Pharma and Hoffmann-La Roche in Switzerland, Japan and the United Kingdom.